deltatrials

Schizophrenia Trials in Oceanside, United States

Conditions / Schizophrenia / Oceanside, United States

Schizophrenia is a medical condition with active clinical research programs worldwide.

90 total trials for this combination

Showing top 10 of 90 trials

Trials

NCT ID Title Status Phase
NCT00528905 Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia COMPLETED PHASE2
NCT05304767 An Extension Study to Assess Long-Term Safety and Tolerability of Adjunctive KarXT in Subjects With Inadequately Controlled Symptoms of Schizophrenia RECRUITING PHASE3
NCT01714713 A 26-Week Extension Study of EVP-6124 (Alpha-7 nAChR) as an Adjunctive Pro-Cognitive Treatment in Schizophrenia Subjects on Chronic Stable Atypical Antipsychotic Therapy COMPLETED PHASE3
NCT01716975 Study of EVP-6124 (Alpha-7 nAChR) as an Adjunctive Pro-Cognitive Treatment in Schizophrenia Subjects on Chronic Stable Atypical Antipsychotic Therapy COMPLETED PHASE3
NCT01515423 Study of Paliperidone Palmitate 3 Month and 1 Month Formulations for the Treatment of Patients With Schizophrenia COMPLETED PHASE3
NCT01714661 Study of EVP-6124 (Alpha-7 nAChR) as an Adjunctive Pro-Cognitive Treatment in Schizophrenia Subjects on Chronic Stable Atypical Antipsychotic Therapy COMPLETED PHASE3
NCT01432444 Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole COMPLETED PHASE3
NCT00396214 Compare the Effects of Bifeprunox and Quetiapine on Weight Changes in Stable Schizophrenic Patients TERMINATED PHASE3
NCT00731549 Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia COMPLETED PHASE3
NCT05145413 A Study to Assess Efficacy and Safety of Adjunctive KarXT in Subjects With Inadequately Controlled Symptoms of Schizophrenia COMPLETED PHASE3

Related Pages